Everleap Fertility Expands Access to Reproductive Healthcare with New Clinic Opening in The Woodlands, Texas
Everleap Fertility, a U.S. fertility care provider formerly known as RMA Houston and part of IVI Institute, has announced the opening of a new full-service fertility clinic in The Woodlands, Texas. The new facility is intended to expand access to reproductive healthcare for individuals and families living and working in the northern suburbs of Houston, providing a wider range of fertility services closer to home.
The opening of Everleap Fertility The Woodlands marks the company’s second clinic location in Texas and represents an expansion of its existing presence in the Greater Houston metropolitan area. Located at 9303 New Trails Drive, Suite 100, the clinic will provide fertility evaluations, treatment options and family-building services to patients seeking support at different stages of their reproductive journeys.
As a provider focused on fertility care, Everleap Fertility offers treatments and services designed to address a range of reproductive health needs. Its offerings include in vitro fertilization (IVF), intrauterine insemination (IUI), preimplantation genetic testing (PGT), egg freezing, and donor egg, donor sperm and gestational surrogacy services. The organization also provides family-planning resources for LGBTQ+ individuals and fertility preservation options for people facing medical conditions such as cancer and autoimmune diseases.
The new location is designed to make these services more accessible to residents of The Woodlands and surrounding northern Houston communities. By bringing fertility specialists and treatment services closer to patients, Everleap Fertility aims to reduce the travel and scheduling challenges that can affect decisions about seeking reproductive healthcare.
Dr. Caroline Juneau, a reproductive endocrinologist and infertility specialist practicing at the new clinic, described The Woodlands as a natural extension of the organization’s established Houston practice.
“The Woodlands is a natural extension of our existing Houston practice, allowing us to bring advanced fertility care closer to patients in the northern Houston suburbs who may find it difficult or inconvenient to travel into the city for appointments,” Dr. Juneau said.
The expansion reflects the organization’s focus on improving geographic access to fertility services while maintaining the clinical standards and patient experience associated with its existing practice.
New Clinic Strengthens Everleap Fertility’s Presence in Greater Houston
The opening of Everleap Fertility The Woodlands represents an important development in the company’s efforts to serve a broader patient population across the Greater Houston region. The clinic’s location is intended to provide greater convenience for individuals and couples who previously may have needed to travel farther into Houston to access fertility consultations and treatment.
Fertility care often involves multiple appointments, diagnostic assessments, treatment procedures and follow-up visits. Depending on the treatment plan, patients may need to visit a clinic regularly over an extended period. Travel distance can therefore become a practical consideration when choosing a fertility provider or deciding whether to begin treatment.
For people living in communities outside central Houston, traveling into the city for repeated appointments may create additional logistical challenges. These can include time away from work, transportation arrangements, childcare responsibilities and the need to coordinate visits with other personal commitments.
By establishing a full-service facility in The Woodlands, Everleap Fertility aims to make it easier for patients in northern Houston suburbs to access reproductive specialists and available treatment options. The location also extends the organization’s ability to provide fertility services within a growing suburban community.
The clinic will serve as the company’s second Texas location, building on the foundation of its existing Houston practice. Its opening is part of a broader effort to expand access to reproductive medicine and support people who may need assistance with infertility, fertility preservation or alternative family-building options.
As part of IVI Institute, Everleap Fertility is connected to an international reproductive medicine organization. This affiliation provides the broader organizational context for its work in fertility care and its focus on providing treatment options for individuals and families with different reproductive needs.
Comprehensive Fertility Treatments and Family-Building Services
Everleap Fertility offers a range of fertility treatments intended to support patients with different medical circumstances, reproductive goals and family-building preferences. The new Woodlands clinic will extend access to the organization’s services in the northern Houston area.
One of the principal treatments offered by the organization is in vitro fertilization, commonly known as IVF. IVF is an assisted reproductive technology in which eggs are retrieved from the ovaries and fertilized with sperm in a laboratory setting. Embryos may then be assessed and, when appropriate, transferred into the uterus as part of a treatment cycle.
IVF may be considered by individuals and couples experiencing different forms of infertility. Treatment recommendations depend on factors such as reproductive health, medical history, age and previous treatment outcomes. Fertility specialists evaluate these considerations to help determine an appropriate approach for each patient.
The organization also provides intrauterine insemination (IUI), a fertility treatment that involves placing prepared sperm directly into the uterus around the time of ovulation. IUI may be an option for certain patients depending on their fertility evaluation and clinical circumstances.
Another service offered by Everleap Fertility is preimplantation genetic testing (PGT). This testing can be used to assess embryos for specific genetic or chromosomal characteristics before an embryo transfer. The type of testing considered depends on the patient’s medical history, reproductive goals and clinical recommendations.
For individuals who wish to preserve their reproductive options, the clinic also offers egg freezing. This process involves collecting and freezing eggs for potential future use. Fertility preservation may be considered for personal or medical reasons, including situations in which a person expects to delay pregnancy or is preparing for treatment that could affect reproductive function.
In addition to treatments involving a patient’s own eggs or sperm, Everleap Fertility provides donor egg and donor sperm services. These options may help individuals and couples who require donor assistance as part of their family-building plans.
The organization also offers gestational surrogacy services for patients who need another person to carry a pregnancy. These services provide an additional pathway for people whose medical or reproductive circumstances make carrying a pregnancy difficult or unsuitable.
By offering several treatment and family-building options, Everleap Fertility aims to support patients with different needs rather than relying on a single approach to reproductive care. The availability of these services can help patients discuss potential pathways with fertility specialists and consider options based on their individual circumstances.
Supporting LGBTQ+ Family Planning and Fertility Preservation
Everleap Fertility’s services also extend to individuals and families seeking support with family planning beyond conventional infertility treatment.
The organization provides family-planning resources and options for LGBTQ+ individuals. These services are intended to help people explore reproductive choices and understand the pathways available to them as they plan to build families.
Family-building needs can vary significantly among individuals and couples. Depending on their circumstances, patients may consider donor eggs, donor sperm, IVF, gestational surrogacy or combinations of these services. Access to fertility specialists can help individuals understand the available options and identify approaches that align with their reproductive goals.
Everleap Fertility also offers fertility preservation services for people facing medical conditions that may affect reproductive health. Cancer diagnoses and autoimmune diseases can create circumstances in which patients need to consider the potential effects of their condition or treatment on future fertility.
Certain medical treatments may affect reproductive function, making fertility preservation an important consideration before treatment begins. Depending on the patient’s circumstances, options such as egg freezing may be discussed as part of the broader care-planning process.
Providing access to fertility preservation services is particularly relevant for patients who need to balance immediate medical treatment with longer-term family-building goals. Coordination between fertility specialists and other healthcare professionals may help patients understand the timing and suitability of available options.
Through its range of reproductive services, Everleap Fertility aims to provide support to people at different stages of life and across a variety of medical and personal situations.
Fertility Barometer Highlights Barriers to Accessing Treatment
The expansion into The Woodlands comes against a backdrop of continuing demand for fertility services and evidence that access remains a challenge for many people considering treatment.
According to U.S. findings from the IVI Institute Fertility Barometer, becoming a mother is an important life goal for most women surveyed. More than half of respondents described motherhood as one of their highest personal priorities.
However, the findings also highlight that infertility is more common than many people may realize. One in five women in the United States between the ages of 19 and 49 reported having experienced infertility at some point in their lives.
Although the desire to have children remains an important consideration for many women, the decision to pursue fertility treatment can involve several personal, medical and practical factors. Patients may need to consider treatment costs, medical requirements, appointment schedules, emotional demands and the availability of appropriate fertility services.
The Fertility Barometer also identified geographic distance and waiting lists as perceived barriers to accessing treatment. Nearly 38% of surveyed respondents cited waiting lists and distance to clinics as factors that could make fertility treatment more difficult to pursue.
These findings point to the importance of access when considering how patients engage with fertility services. Even when individuals are interested in seeking medical support, practical obstacles can influence whether they begin treatment, which provider they choose and how easily they can attend the appointments required throughout a treatment process.
The distance between a patient’s home or workplace and a fertility clinic may be particularly important because reproductive treatment can involve several visits over a relatively short period. Patients may need to attend consultations, monitoring appointments, procedures and follow-up assessments, depending on the treatment pathway.
For people living in suburban and surrounding communities, a clinic located closer to home may help reduce the time and travel involved in accessing care.
Expanding Access for Patients in Northern Houston Suburbs
Dr. Nola Herlihy, medical director, physician partner and reproductive endocrinology and infertility specialist at Everleap Fertility, emphasized that geographic access is an important factor in whether individuals seek fertility treatment.
“We know that distance from a clinic is a key factor in whether people seek treatment, and expanding our presence in the Greater Houston area will make it easier for the one in five Texans facing infertility to access the care they need and begin their family-building journey,” Dr. Herlihy said.
She added that the clinical team is looking forward to bringing the organization’s established standards of care and patient experience to the growing Woodlands community.
“Our team is excited to bring the same high standard of care, excellent patient experience, and industry-leading outcomes that Everleap Fertility is known for to this growing community,” she said.
Herlihy’s comments underscore the company’s view that expanding its physical presence can help address one of the practical challenges associated with fertility treatment. Establishing a clinic in The Woodlands may make consultations and ongoing care more convenient for patients who live or work in northern Houston communities.
The new location is intended to complement, rather than replace, the organization’s existing Houston practice. By operating across two Texas locations, Everleap Fertility can extend its geographic reach and provide patients with additional access points for reproductive healthcare.
The expansion may also help patients explore the range of available services without having to travel into central Houston for every stage of their care. The actual treatment plan and location of specific procedures will depend on the services available and each patient’s clinical needs.
IVI Institute Affiliation Supports the Organization’s Reproductive Medicine Focus
Everleap Fertility is part of IVI Institute, which is recognized as a global leader in reproductive medicine. The affiliation connects the U.S. fertility provider with a broader organization focused on reproductive healthcare and assisted reproductive technologies.
Formerly known as RMA Houston, Everleap Fertility has developed its identity around providing fertility services and supporting patients through different stages of family building. The transition to the Everleap Fertility name reflects the organization’s current brand identity while maintaining its focus on reproductive care.
The company’s service portfolio covers infertility treatment, fertility preservation, donor-assisted reproduction and family-planning options. These offerings reflect the range of circumstances that can lead individuals and couples to seek fertility support.
The Woodlands clinic extends this service offering into another part of the Houston metropolitan area. Its opening also demonstrates the organization’s continued investment in expanding access to reproductive healthcare in Texas.
Supporting More Accessible Fertility Care in Texas
With the opening of Everleap Fertility The Woodlands, the company is seeking to address geographic barriers that may prevent some people from pursuing fertility treatment. The full-service clinic at 9303 New Trails Drive, Suite 100, becomes the organization’s second location in Texas and expands its presence across the Greater Houston region.
The new facility will provide access to a broad range of fertility treatments and family-building services, including IVF, IUI, PGT, egg freezing, donor egg and sperm options, and gestational surrogacy services. It will also support family planning for LGBTQ+ individuals and fertility preservation for patients facing cancer diagnoses or autoimmune diseases.
The expansion comes as findings from the IVI Institute Fertility Barometer highlight the prevalence of infertility and the practical challenges that can affect access to care. With one in five U.S. women aged 19–49 reporting a history of infertility and nearly 38% of respondents identifying waiting lists and clinic distance as perceived barriers, improving the availability and convenience of fertility services remains an important consideration.
Everleap Fertility aims to bring its existing clinical expertise and patient-focused approach closer to residents of The Woodlands and surrounding communities. Through the new location, the organization intends to make it easier for individuals and families to connect with reproductive specialists, explore available treatment options and take steps toward their family-building goals.
About Everleap Fertility
Built on the legacy of RMA, Boston IVF, Conceptions, and six other leading North American fertility practices, Everleap Fertility brings together physicians and embryologists across 65+ locations in the U.S., including 25 IVF laboratories focused on the next leap forward in reproductive medicine. Together, we have helped hundreds of thousands of patients build families for more than 40 years. As part of IVI Institute, Everleap Fertility contributes to a global community working together to advance the field and bring progress in reproductive medicine into patient care. For more information, visit everleapfertility.com.
About IVI Institute
IVI Institute is the global leader in reproductive medicine, bringing together world-class fertility clinics and expertise to advance the future of fertility care around the world. With 100+ babies born every day across more than 200 locations in 15 countries – including IVI Fertility, Everleap Fertility, LIVIO, Create Fertility, and TRIO clinics, among other brands – IVI Institute accelerates innovation, expands knowledge, and improves outcomes for patients around the world through groundbreaking research, collaboration, and rigorous clinical standards. Learn more at www.iviinstitute.com.